179 related articles for article (PubMed ID: 11707436)
1. Physiological substrates for human lysosomal beta -hexosaminidase S.
Hepbildikler ST; Sandhoff R; Kolzer M; Proia RL; Sandhoff K
J Biol Chem; 2002 Jan; 277(4):2562-72. PubMed ID: 11707436
[TBL] [Abstract][Full Text] [Related]
2. Specificity of mouse GM2 activator protein and beta-N-acetylhexosaminidases A and B. Similarities and differences with their human counterparts in the catabolism of GM2.
Yuziuk JA; Bertoni C; Beccari T; Orlacchio A; Wu YY; Li SC; Li YT
J Biol Chem; 1998 Jan; 273(1):66-72. PubMed ID: 9417048
[TBL] [Abstract][Full Text] [Related]
3. Identification of candidate active site residues in lysosomal beta-hexosaminidase A.
Fernandes MJ; Yew S; Leclerc D; Henrissat B; Vorgias CE; Gravel RA; Hechtman P; Kaplan F
J Biol Chem; 1997 Jan; 272(2):814-20. PubMed ID: 8995368
[TBL] [Abstract][Full Text] [Related]
4. Degradation of membrane-bound ganglioside GM2 by beta -hexosaminidase A. Stimulation by GM2 activator protein and lysosomal lipids.
Werth N; Schuette CG; Wilkening G; Lemm T; Sandhoff K
J Biol Chem; 2001 Apr; 276(16):12685-90. PubMed ID: 11278374
[TBL] [Abstract][Full Text] [Related]
5. Identification of domains in human beta-hexosaminidase that determine substrate specificity.
Pennybacker M; Liessem B; Moczall H; Tifft CJ; Sandhoff K; Proia RL
J Biol Chem; 1996 Jul; 271(29):17377-82. PubMed ID: 8663217
[TBL] [Abstract][Full Text] [Related]
6. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice.
Itakura T; Kuroki A; Ishibashi Y; Tsuji D; Kawashita E; Higashine Y; Sakuraba H; Yamanaka S; Itoh K
Biol Pharm Bull; 2006 Aug; 29(8):1564-9. PubMed ID: 16880605
[TBL] [Abstract][Full Text] [Related]
7. A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside.
Sharma R; Bukovac S; Callahan J; Mahuran D
Biochim Biophys Acta; 2003 Jan; 1637(1):113-8. PubMed ID: 12527415
[TBL] [Abstract][Full Text] [Related]
8. Photoaffinity labeling of human lysosomal beta-hexosaminidase B. Identification of Glu-355 at the substrate binding site.
Liessem B; Glombitza GJ; Knoll F; Lehmann J; Kellermann J; Lottspeich F; Sandhoff K
J Biol Chem; 1995 Oct; 270(40):23693-9. PubMed ID: 7559539
[TBL] [Abstract][Full Text] [Related]
9. Identification of the 6-sulfate binding site unique to alpha-subunit-containing isozymes of human beta-hexosaminidase.
Sharma R; Deng H; Leung A; Mahuran D
Biochemistry; 2001 May; 40(18):5440-6. PubMed ID: 11331008
[TBL] [Abstract][Full Text] [Related]
10. The specificity of human N-acetyl-beta-D-hexosaminidases towards glycosphincolipids is determined by an activator protein.
Conzelmann E; Sandhoff K
Adv Exp Med Biol; 1980; 125():295-306. PubMed ID: 6444774
[TBL] [Abstract][Full Text] [Related]
11. Identification of an active acidic residue in the catalytic site of beta-hexosaminidase.
Tse R; Vavougios G; Hou Y; Mahuran DJ
Biochemistry; 1996 Jun; 35(23):7599-607. PubMed ID: 8652542
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.
Mark BL; Mahuran DJ; Cherney MM; Zhao D; Knapp S; James MN
J Mol Biol; 2003 Apr; 327(5):1093-109. PubMed ID: 12662933
[TBL] [Abstract][Full Text] [Related]
13. Formation of a ternary complex between GM2 activator protein, GM2 ganglioside and hexosaminidase A.
Yadao F; Hechtman P; Kaplan F
Biochim Biophys Acta; 1997 Jun; 1340(1):45-52. PubMed ID: 9217013
[TBL] [Abstract][Full Text] [Related]
14. The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A.
Meier EM; Schwarzmann G; Fürst W; Sandhoff K
J Biol Chem; 1991 Jan; 266(3):1879-87. PubMed ID: 1824846
[TBL] [Abstract][Full Text] [Related]
15. I. Abnormalities in cells of the testis, efferent ducts, and epididymis in juvenile and adult mice with beta-hexosaminidase A and B deficiency.
Adamali HI; Somani IH; Huang JQ; Mahuran D; Gravel RA; Trasler JM; Hermo L
J Androl; 1999; 20(6):779-802. PubMed ID: 10591618
[TBL] [Abstract][Full Text] [Related]
16. A Pro504 --> Ser substitution in the beta-subunit of beta-hexosaminidase A inhibits alpha-subunit hydrolysis of GM2 ganglioside, resulting in chronic Sandhoff disease.
Hou Y; McInnes B; Hinek A; Karpati G; Mahuran D
J Biol Chem; 1998 Aug; 273(33):21386-92. PubMed ID: 9694901
[TBL] [Abstract][Full Text] [Related]
17. II. Characterization and development of the regional- and cellular-specific abnormalities in the epididymis of mice with beta-hexosaminidase A deficiency.
Adamali HI; Somani IH; Huang JQ; Gravel RA; Trasler JM; Hermo L
J Androl; 1999; 20(6):803-24. PubMed ID: 10591619
[TBL] [Abstract][Full Text] [Related]
18. Metabolic correction in microglia derived from Sandhoff disease model mice.
Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Itoh K
J Neurochem; 2005 Sep; 94(6):1631-8. PubMed ID: 16092933
[TBL] [Abstract][Full Text] [Related]
19. Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates.
Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Kuwahara J; Yamanaka S; Itoh K
J Neurochem; 2005 Mar; 92(6):1497-507. PubMed ID: 15748167
[TBL] [Abstract][Full Text] [Related]
20. Direct determination of the substrate specificity of the alpha-active site in heterodimeric beta-hexosaminidase A.
Hou Y; Tse R; Mahuran DJ
Biochemistry; 1996 Apr; 35(13):3963-9. PubMed ID: 8672428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
